Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Prof Lars Fugger
Prof Lars Fugger

Congratulations for their recent success go to:

Prof Lars Fugger - Wellcome Trust Senior Investigator Award

Prof Fugger received the award for his work on Multiple Sclerosis. His group is seeking to understand the molecular basis for interactions between genetic and environmental risk factors through a multidisciplinary approach, which combines analysis of both clinical samples and humanised transgenic in vivo models. Their goal is to develop new therapeutic avenues for MS by gaining insight into disease pathways, which can be manipulated through both novel drugs and drug repositioning. 

Prof Fugger trained at the University of Copenhagen and at Stanford University. He became Professor of Clinical Immunology at the University of Oxford in 2004 and Professor of Neuroimmunology in 2007 in the NDCN.

Prof Kia Nobre – MRC Partnership Grant

Prof Kia Nobre and colleagues at the Oxford Centre for Human Brain Activity were part of a collaboration of MEG researchers across the UK to receive a £1.3m Partnership Grant from the MRC to enhance MEG training, collaboration, and data sharing.

Dr Martin Turner – MRC Senior Clinician Scientist Fellowship

Dr Turner is a Consultant Neurologist and Clinician Scientist in NDCN. His research focus is the neurodegenerative disorder Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS) in its commonest form.

Dr Gwenaelle Douaud – MRC Career Development Award

Dr Douaud is part of the FMRIB Analysis Group. She focuses on translational research from imaging methods to applied human neuroscience, such as brain maturation and ageing, and with a particular emphasis on neurodegenerative disorders (Alzheimer's disease, movement disorders and motor neuron disease).

Dr Chris Butler - MRC Scientist-Clinician Fellowship

Dr Butler is investigating the functional and neural basis of accelerated forgetting in patients with transient epileptic amnesia.

 

Similar stories

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Clinical Neurology Research

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Clinical Neurology Research

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Clinical Neurology Coronavirus Research

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Clinical Neurology Coronavirus Research

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

Viruses shown to evolve as a result of different immune responses in different ethnic populations

Clinical Neurology Coronavirus Research

New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.

Emerging Leaders Prize celebrates outstanding pain researchers

Award Clinical Neurology

2020’s Emerging Leaders Prize awards £200,000 to outstanding scientists from the University of Oxford, University College London and King’s College London, who are all working in the field of pain research.